Cellular &Biotherapies

Versiti partners with hospitals, biopharma innovators, and academic researchers to support the full continuum of cellular therapy development and care—from therapeutic apheresis at the bedside to leukopak collections and cell processing for research and manufacturing. 

With more than 75 years of expertise in transfusion medicine, Versiti collaborates with leading healthcare systems and biopharmaceutical companies to deliver high-quality cellular starting materials and clinical services.  

Versiti delivers specialized therapeutic apheresis procedures and cellular therapy collections that accelerate treatments and strengthen clinical teams. We bring more than 75 years of transfusion medicine expertise to every procedure, serving 20+ hospitals across the Midwest with 6,000+ procedures performed annually. Our physicians, nurses, and staff work as an extension of your care team to deliver precision, compassion, and scientific rigor from bedside to bench. 

We collect high-quality mononuclear cells and therapeutic products for research and clinical applications. As a donor-centered partner, we bridge clinical-grade standards with research flexibility to provide cells that meet the precision, consistency, and regulatory readiness your work demands. Our approach connects compassionate patient care with scientific discovery, helping partners move confidently from innovation to life-changing therapies. 

Our service hubs in Milwaukee, Grand Rapids, Indianapolis, and Dayton serve patients throughout the Midwest. We extend care up to four hours beyond these locations, ensuring broader access to specialized therapeutic services. 

Specialized collections supporting the next generation of cell and gene therapies.

Cellular therapies—including CAR-T cell therapy, gene therapies, and immune cell–based treatments—require reliable access to high-quality starting materials and expert collection procedures. 

Versiti supports autologous and allogeneic cellular therapy collections, helping healthcare systems and biopharma partners safely obtain the cells required for advanced therapy manufacturing. 

Versiti supports CAR-T cell collections for both clinical trials and commercial therapies, helping bring life-changing treatments to patients nationwide. Our clinical teams operate as an extension of your care program—combining bedside expertise, donor management, and regulatory readiness to support rapidly evolving cellular therapy programs.

Powering Cutting-Edge Advancements in Medical Research

The future of cellular and immune therapies requires high-quality human blood products to drive breakthroughs in clinical research. Versiti empowers biopharma, clinical, and academic researchers with a comprehensive portfolio of blood components, as well as an unmatched expertise in blood collection, apheresis procedures, and donor management. Versiti provides the critical biological materials that drive discovery forward, from developing CAR-T therapies to studying immune cell function or optimizing cell expansion protocols.

Expertise Across the Cellular Therapy Ecosystem

Versiti uniquely integrates clinical services, donor management, biomaterials collection, and translational research expertise within one organization.

Key differentiators include:

• Deep transfusion medicine expertise
  More than 75 years of leadership in blood health, apheresis procedures, and donor management.
• Integrated clinical and research infrastructure
  Our teams support both patient-care procedures and research collections, ensuring consistency from bedside to bench.
• Established donor networks
  Our contributor programs enable efficient recruitment, screening, and recall of donors for specialized cellular collections.
• Quality and regulatory alignment
  Collections are conducted under IRB-approved protocols and can support research, clinical trials, and manufacturing applications.
• Collaborative partnership model
  We work as an extension of your clinical or research team—providing expertise, consultation, and flexible solutions tailored to your program.